Top compounds associated with response to CTNND2


Feature Type Standardized
Nominal ANOVA
mRNA lenalidomide GDSC1000 pan-cancer AAC -0.017 0.6
mRNA EKB-569 GDSC1000 pan-cancer AAC -0.015 0.6
mRNA RDEA119 FIMM pan-cancer AAC -0.08 0.6
mRNA Salubrinal GDSC1000 pan-cancer AAC 0.026 0.6
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.015 0.6
mRNA VU0155056 CTRPv2 pan-cancer AAC 0.017 0.6
mRNA BRD-K96970199 CTRPv2 pan-cancer AAC -0.037 0.7
mRNA MLN2480 CTRPv2 pan-cancer AAC -0.024 0.7
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.016 0.7
mRNA AP-24534 GDSC1000 pan-cancer AAC -0.015 0.7
Download CSV